CSPC Pharma Developing Patented Drugs

China Shijiazhuang Pharma (CSPC), a company that has traditionally been known as a maker of bulk pharmaceuticals, is expanding into patented, innovative drugs. The company said it would focus on five disease sectors: cardiovascular, cerebrovascular, neurology, endocrinology (diabetes) as well as metabolism/digestion. More details.... Stock Symbol: (HK: 1093) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});